Evidence map›Paper›PMID 37979092›Full record

ArticleJournal of neurology2024

Plasma GFAP and its association with disease severity in Huntington's disease.

Kübra Tan, Melanie Alpaugh, Nicholas J Ashton, Sylvain Chouinard, Roger A Barker, Kaj Blennow, Henrik Zetterberg, Francesca Cicchetti, Andréa L Benedet

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Kübra TanDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden.
Melanie AlpaughDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Canada.
Nicholas J AshtonDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden.
Sylvain ChouinardMovement Disorders Unit, CHUM, Centre Hospitalier Universitaire de Montréal-Hôtel Dieu, Montréal, QC, Canada.
Roger A BarkerJohn Van Geest Center for Brain Repair, Department of Clinical Neuroscience, University of Cambridge, Cambridge, UK.
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden.
Francesca CicchettiDépartement de Psychiatrie & Neurosciences, Faculté de Médecine, Université Laval, Québec, Canada.
Andréa L BenedetDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80, Mölndal, Sweden. andrea.benedet@gu.se.ORCID http://orcid.org/0000-0001-8219-1741
University of Gothenburg · SEKing's College London · GBSahlgrenska University Hospital · SEUniversité Laval · CAUniversity of Cambridge · GBUniversity of Guelph · CAUniversity of Wisconsin–Madison · US

Funding

CIHR PJT-168865
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Huntington DiseaseHumansPatient AcuitySeverity of Illness Index

Identifiers

PMID37979092
OpenAlexW4388797431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.